CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.

Saved in:
Bibliographic Details
Title: CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.
Authors: Moser LM; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Heim C; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Koschade SE; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany., Wendel P; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany., Bozkurt S; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany., Harenkamp S; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany., Kreyenberg H; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Merker M; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany., Münch C; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Frankfurt am Main, Germany., Gradhand E; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany., Vogler M; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute for Experimental Pediatric Hematology and Oncology, Goethe University, Frankfurt am Main, Germany., Ullrich E; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany., Bönig H; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, United States., Klusmann JH; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Bader P; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany., Wels WS; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany., Rettinger E; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.
Source: Frontiers in immunology [Front Immunol] 2025 Feb 03; Vol. 16, pp. 1485817. Date of Electronic Publication: 2025 Feb 03 (Print Publication: 2025).
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39963129
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Moser+LM%22">Moser LM</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Heim+C%22">Heim C</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Koschade+SE%22">Koschade SE</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wendel+P%22">Wendel P</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.; Institute for Organic Chemistry and Biochemistry, Technical University of Darmstadt, Darmstadt, Germany.<br /><searchLink fieldCode="AU" term="%22Bozkurt+S%22">Bozkurt S</searchLink>; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Harenkamp+S%22">Harenkamp S</searchLink>; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Kreyenberg+H%22">Kreyenberg H</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Merker+M%22">Merker M</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Münch+C%22">Münch C</searchLink>; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute of Biochemistry II, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.; Cardio-Pulmonary Institute, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Gradhand+E%22">Gradhand E</searchLink>; Department of Pediatric and Perinatal Pathology, Dr. Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Vogler+M%22">Vogler M</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Institute for Experimental Pediatric Hematology and Oncology, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Ullrich+E%22">Ullrich E</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.; Experimental Immunology & Cell Therapy, Department of Pediatrics, Goethe University, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Bönig+H%22">Bönig H</searchLink>; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Klusmann+JH%22">Klusmann JH</searchLink>; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Bader+P%22">Bader P</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Wels+WS%22">Wels WS</searchLink>; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.<br /><searchLink fieldCode="AU" term="%22Rettinger+E%22">Rettinger E</searchLink>; Division for Stem Cell Transplantation and Immunology, Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; Department of Pediatrics, Goethe University Frankfurt, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt am Main, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2025 Feb 03; Vol. 16, pp. 1485817. <i>Date of Electronic Publication: </i>2025 Feb 03 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39963129
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2025.1485817
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1485817
    Titles:
      – TitleFull: CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Moser LM
      – PersonEntity:
          Name:
            NameFull: Heim C
      – PersonEntity:
          Name:
            NameFull: Koschade SE
      – PersonEntity:
          Name:
            NameFull: Wendel P
      – PersonEntity:
          Name:
            NameFull: Bozkurt S
      – PersonEntity:
          Name:
            NameFull: Harenkamp S
      – PersonEntity:
          Name:
            NameFull: Kreyenberg H
      – PersonEntity:
          Name:
            NameFull: Merker M
      – PersonEntity:
          Name:
            NameFull: Münch C
      – PersonEntity:
          Name:
            NameFull: Gradhand E
      – PersonEntity:
          Name:
            NameFull: Vogler M
      – PersonEntity:
          Name:
            NameFull: Ullrich E
      – PersonEntity:
          Name:
            NameFull: Bönig H
      – PersonEntity:
          Name:
            NameFull: Klusmann JH
      – PersonEntity:
          Name:
            NameFull: Bader P
      – PersonEntity:
          Name:
            NameFull: Wels WS
      – PersonEntity:
          Name:
            NameFull: Rettinger E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 02
              Text: 2025 Feb 03
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1